London CO Of Virginia Eli Lilly & CO Transaction History

London CO Of Virginia

$18.6 Billion
Q3 2024

A detailed history of London CO Of Virginia transactions in Eli Lilly & CO stock. As of the latest transaction made, London CO Of Virginia holds 23,799 shares of LLY stock, worth $17.8 Million. This represents 0.11% of its overall portfolio holdings.

Number of Shares

23,799

Previous 24,605 3.28%

Holding current value

$17.8 Million

Previous $22.3 Million 5.35%

% of portfolio

0.11%

Previous 0.13%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$772.14 - $960.02 $622,344 - $773,776	-806 Reduced 3.28%	23,799 $21.1 Million
Q2 2024 Aug 14, 2024	SELL	$724.87 - $909.04 $513,207 - $643,600	-708 Reduced 2.8%	24,605 $22.3 Million
Q4 2023 Feb 14, 2024	SELL	$525.19 - $619.13 $179,089 - $211,123	-341 Reduced 1.33%	25,313 $14.8 Million
Q3 2023 Nov 14, 2023	BUY	$434.7 - $599.3 $942,429 - $1.3 Million	2,168 Added 9.23%	25,654 $13.8 Million
Q1 2023 May 15, 2023	SELL	$310.63 - $364.82 $633,685 - $744,232	-2,040 Reduced 7.99%	23,486 $8.07 Million
Q4 2022 Feb 14, 2023	SELL	$321.55 - $374.67 $522,197 - $608,464	-1,624 Reduced 5.98%	25,526 $9.34 Million
Q3 2022 Nov 14, 2022	SELL	$296.48 - $337.87 $9,190 - $10,473	-31 Reduced 0.11%	27,150 $8.78 Million
Q2 2022 Aug 15, 2022	BUY	$278.73 - $327.27 $217,688 - $255,597	781 Added 2.96%	27,181 $8.81 Million
Q1 2022 May 16, 2022	BUY	$234.69 - $291.66 $51,631 - $64,165	220 Added 0.84%	26,400 $7.56 Million
Q4 2021 Feb 14, 2022	SELL	$224.85 - $279.04 $153,347 - $190,305	-682 Reduced 2.54%	26,180 $7.23 Million
Q3 2021 Nov 15, 2021	BUY	$221.6 - $272.71 $135,176 - $166,353	610 Added 2.32%	26,862 $6.21 Million
Q4 2019 Feb 14, 2020	SELL	$106.92 - $132.43 $296,168 - $366,831	-2,770 Reduced 9.54%	26,252 $3.45 Million
Q2 2019 Aug 14, 2019	SELL	$110.79 - $129.32 $1,329 - $1,551	-12 Reduced 0.04%	29,022 $3.22 Million
Q1 2019 May 14, 2019	SELL	$111.31 - $131.02 $40,516 - $47,691	-364 Reduced 1.24%	29,034 $3.77 Million
Q4 2018 Feb 14, 2019	BUY	$105.9 - $118.64 $1.04 Million - $1.17 Million	9,823 Added 50.18%	29,398 $3.4 Million
Q3 2018 Nov 14, 2018	BUY	$85.86 - $107.31 $51,086 - $63,849	595 Added 3.13%	19,575 $2.1 Million
Q2 2018 Aug 14, 2018	SELL	$75.7 - $86.88 $89 Million - $102 Million	-1,176,331 Reduced 98.41%	18,980 $1.62 Million
Q1 2018 May 15, 2018	SELL	$74.21 - $87.6 $197 Million - $233 Million	-2,658,463 Reduced 68.98%	1,195,311 $92.5 Million
Q4 2017 Feb 13, 2018	SELL	$81.94 - $87.89 $20.9 Million - $22.5 Million	-255,455 Reduced 6.22%	3,853,774 $325 Million
Q3 2017 Nov 14, 2017	BUY	$77.07 - $85.54 $317 Million - $352 Million	4,109,229	4,109,229 $352 Million

Others Institutions Holding LLY

# of Institutions

4,004

Shares Held

752M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $711B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of London CO Of Virginia, based on Form 13F filings with the SEC.

News

Stay updated on London CO Of Virginia with notifications on news.

Account

London CO Of Virginia Eli Lilly & CO Transaction History